Abstract | HISTORY AND ADMISSION FINDINGS: INVESTIGATIONS: DIAGNOSIS, TREATMENT AND COURSE: CONCLUSION:
Steroids should be given to known hepatitis B carriers only if strictly indicated, because of the danger of acute deterioration of liver functions by reactivation of the disease with possibly fatal consequences. If steroids are administered, liver functions and serological hepatitis markers should be closely monitored so that any necessary treatment can be quickly initiated.
|
Authors | A Hammond, C Ramersdorfer, K D Palitzsch, J Schölmerich, G Lock |
Journal | Deutsche medizinische Wochenschrift (1946)
(Dtsch Med Wochenschr)
Vol. 124
Issue 22
Pg. 687-90
(Jun 04 1999)
ISSN: 0012-0472 [Print] Germany |
Vernacular Title | Letales Leberversagen nach Corticosteroidtherapie bei Hepatitis-B-Carrier-Status. |
PMID | 10394348
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Chemical References |
- Adrenal Cortex Hormones
- Hepatitis B Antibodies
|
Topics |
- Adrenal Cortex Hormones
(adverse effects, therapeutic use)
- Aged
- Carrier State
- Fatal Outcome
- Hepatitis B
(drug therapy, enzymology, immunology)
- Hepatitis B Antibodies
(blood)
- Humans
- Liver Failure
(chemically induced, enzymology, immunology)
- Male
|